News Releases

News Release

Dr. K. John Morrow, Jr., Noted Geneticist and Molecular Biologist, Joins Meridian Bioscience, Inc.

February 19, 2003 at 9:32 AM EST
CINCINNATI, Feb 19, 2003 (BUSINESS WIRE) -- Meridian Bioscience, Inc., Cincinnati, Ohio (Nasdaq:VIVO) today announced that Dr. K. John Morrow, Jr. has joined its expanding scientific team. Prior to Meridian, Dr. Morrow was Professor of Cell Biology and Biochemistry at Texas Tech University Health Sciences Center in Lubbock, Texas. Dr. Morrow's research expertise is in the field of genetics and molecular systems for immunology. His current research is in the area of genetically engineered antibodies, specifically for use in the diagnosis and treatment of disease. He has authored more than fifty articles published in referee journals, fifty-five review articles, and co-authored a recent book, Antibody Engineering - Technologies, Applications, and Business Opportunities, describing methods and theories of recombinant antibodies.

John A. Kraeutler, President and Chief Operating Officer, said, "The addition of Dr. Morrow to our research teams at Meridian Bioscience, Viral Antigens, Inc., and BIODESIGN adds critical molecular capabilities and adds to our strategic expansion into the biotechnology and early stage drug and vaccine development arenas."

Dr. Morrow said, "I look forward to applying my expertise and the power of gene-based systems to further strengthen Meridian's capabilities in diagnostics, as well as expanding biotechnology opportunities."

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. All Meridian products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers and physician offices in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is

Meridian Bioscience, Inc.
John A. Kraeutler, 513/271-3700

Copyright (C) 2003 Business Wire. All rights reserved.